The results showed that the history of basic liver disease; active stage of hepatitis; primary, recurrent, and secondary cancers; extrahepatic metastasis; size of focal liver lesions; and classification of liver function had a significant influence on the plasma level of Hsp90α. Here, HSP90AA1 is linked to liver disorder.